Cencora Inc. (NYSE: COR) signed a definitive agreement to acquire EyeSouth Partners' retina business for $1.1 billion, the pharmaceutical solutions ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE